Immunomodulatory Activity of MicroRNAs: Potential Implications for Multiple Myeloma Treatment

E-ISSN： 1873-5576|17|9|819-838

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.17, Iss.9, 2017-10, pp. : 819-838

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

MicroRNAs in the Pathobiology of Multiple Myeloma

Current Cancer Drug Targets, Vol. 12, Iss. 7, 2012-09 ,pp. : 823-837

Bentham Science Publishers

Access to resources Recommend Favorite

Strategies to deliver microRNAs as potential therapeutics in the treatment of cardiovascular pathology

By Chistiakov Dimitry A. Sobenin Igor A. Orekhov Alexander N.

Drug Delivery, Vol. 19, Iss. 8, 2012-11 ,pp. : 392-405

Informa Healthcare

Access to resources Recommend Favorite

MicroRNAs as Potential Targets for Treatment of Osteoclast-Related Diseases

Current Drug Targets, Vol. 19, Iss. 5, 2018-03 ,pp. : 422-431

Bentham Science Publishers

Access to resources Recommend Favorite

Immunomodulatory drugs in multiple myeloma

By Zangari Maurizio Elice Francesca Tricot Guido

Expert Opinion on Investigational Drugs, Vol. 14, Iss. 11, 2005-11 ,pp. : 1411-1418

Informa Healthcare

Access to resources Recommend Favorite

Editorial: [Hot Topic: New Approaches in the Treatment of Multiple Myeloma: From Target-based Agents to the New Era of microRNAs (Dedicated to the Memory of Prof. Salvatore Venuta)]

Current Cancer Drug Targets, Vol. 12, Iss. 7, 2012-01 ,pp. : 741-742

Bentham Science Publishers

Access to resources Recommend Favorite